Radiotherapy of unicentric mediastinal Castleman's disease

Chinese Journal of Cancer

Volumn 30, Issue 5, 2011, Pages 351-356

  Li, Yue Min ^a,b   Liu, Peng Hui ^a   Zhang, Yu Hai ^a   Xia, Huo Sheng ^a   Li, Liang Liang ^a   Qu, Yi Mei ^a   Wu, Yong ^a   Han, Shou Yun ^a   Liao, Guo Qing ^a   Pu, Yong Dong ^a  

^a 309TH HOSPITAL OF PLA   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Case report; Castleman's disease; Radiotherapy

Indexed keywords

CD20 ANTIGEN; TUBERCULOSTATIC AGENT;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIAGNOSTIC ERROR; FEMALE; HISTOPATHOLOGY; HOARSENESS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LAPAROTOMY; MEDIASTINUM; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE FRACTIONATION; REMISSION; SYMPTOM; THORAX PAIN; TUBERCULOUS LYMPHADENITIS; WEIGHT REDUCTION; WHOLE BODY IMAGING;

EID: 79958153832     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.010.10402     Document Type: Article

References (16)

1. Chronowski GM, Ha CS, Wilder RB, et al. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy [J]. Cancer, 2001,92(3):670-676.
2. Nistor C, Davidescu M, Ciuche A, et al. A rare case of unicentric plasma cell type Castleman' s disease in the mediastinum [J]. Pneumologia, 2010,59(1):32-35.
3. Karami H, Sahebpour AA, Ghasemi M, et al. Hyaline vascular-type Castleman's disease in the hilum of liver: a case report [J]. Cases J, 2010,3(3):74.
4. Tang JQ, Yang YM, Xiong Y, et al. Surgical treatment and prognosis analysis of localized retroperitoneal Castleman disease: a study of 20 cases [J]. Zhonghua Wai Ke Za Zhi, 2009,47(22):1685-1688. [in Chinese]
5. Naghashpour M, Cualing HD, Szabunio M, et al. Hyaline-vascular castleman disease: a rare cause of solitary subcutaneous soft tissue mass [J]. Am J Dermatopathol, 2010,32(3):293-297.
6. Mahmood N, Suresh HB, Swethadri GK, et al. Ultrasound and Doppler findings in a rare case of Castleman's disease of the parotid [J]. Dentomaxillofac Radiol, 2010,39(1):54-56.
7. Zhu YC, Huang Y, Yao J, et al. A rare case of Castleman's disease of plasma cell type within kidney [J]. Chin Med J (Engl), 2009,122(19):2396-2398.
8. Neuhof D, Debus J. Outcome and late complications of radiotherapy in patients with unicentric Castleman disease [J]. Acta Oncol, 2006,45(8):1126-1131.
9. Bowne WB, Lewis JJ, Filippa DA, et al. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature [J]. Cancer, 1999,85(3): 706-717.
10. Bucher P, Chassot G, Zufferey G, et al. Surgical management of abdominal and retroperitoneal Castleman's disease [J]. World J Surg Oncol, 2005, 3:33-41.
11. Veldhuis GJ, van der Leest AH, de Wolf JT, et al. A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspects [J]. Ann Hematol, 1996,73 (1):47-50.
12. de Vries IA, van Acht MM, Demeyere TB, et al. Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literature [J]. Radiat Oncol, 2010,5(2):7.
13. Casquero A, Barroso A, Fernóndez Guerrero ML, et al. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease [J]. Ann Hematol, 2006,85(3): 185-187.
14. Gérard L, Bérezné A, Galicier L, et al. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial [J]. J Clin Oncol, 2007,25(22):3350-3356.
15. Stary G, Kohrgruber N, Herneth AM, et al. Complete regression of HIV-as sociated multicentric Castleman disease treated with rituximab and thalidomide [J]. AIDS, 2008,22(10): 1232-1234.
16. Sobas MA, Alonso Vence N, Diaz Arias J, et al. Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-PO EMS variant) [J]. Ann Hematol, 2010,89(2):217-219.